Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-25-000048

Director sold 3,339 shares at $20.81 ($69,485)

From the SEC's structured data for this filing

Trades in this filing

Krognes Steve E. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-01-07 Sale : show line 1 in the form −3,339 $20.81 $69,485 25,757 D
Open-market sales · 3,339 sh · avg $20.81 · $69,485
Loading xslF345X05/wk-form4_1736385830.xml…